The Street’s Key Stock Analysts Research Reports
$ARCX, $ATVI, $AEO, $ARRS, $CLF, $DLPH, $LULU, $MRO, $MCD, $NFLX, $RL
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of the Street’s Key analysts outlook for main issues for Tuesday, as follows:
AcelRx Pharmaceuticals Inc. (NASDAQ:ACRX) was raised to Buy from Hold and given an 8 price target at Jefferies.
Activision Blizzard Inc. (NASDAQ:ATVI) was raised to Overweight from Equal Weight at Barclays, which also raised the target price to 86 from 79.
American Eagle Outfitters Inc. (NYSE:AEO) analysts raised AEO to Outperform from Neutral and the price target was set at 29 at Wedbush Securities.
ARRIS International PLC (NASDAQ:ARRS) was downgraded to Outperform from Strong Buy and the target price was cut to 29 from $6 at Raymond James.
Cleveland-Cliffs Inc. (NYSE:CLF) analysts downgraded CLF to Neutral from Outperform at Credit Suisse. Its consensus target price is 13.00.
Delphi Technologies PLC (NYSE:DLPH) analysts downgraded to Equal Weight from Overweight at Morgan Stanley. The consensus target price is $39.21.
Lululemon Athletica Inc. (NASDAQ:LULU) was raised to Outperform from Neutral with a 176 price target at Wedbush. Lululemon has a consensus target price of 163.83 ahead of it earnings call.
Marathon Oil Corp. (NYSE:MRO) analysts raised to Outperform from Market Perform at BMO Capital Markets. Marathon Oil has a consensus target price of 24.59.
McDonald’s Corp. (NYSE:MCD) was raised to Outperform from In-Line at Evercore ISI. McDonald’s closed at Monday at 163.67, compared with a consensus target price of 184.85.
Netflix Inc. (NASDAQ:NFLX) analyst maintained as Buy at Goldman Sachs, the firm lowered its price target to 430 from 470 ahead of Tuesday’s earnings report. NFLX has a consensus target price at 380.83.
Ralph Lauren Corp. (NYSE:RL) was raised to Overweight from Neutral and that price target was raised to 150 at JPMorgan.